Results 191 to 200 of about 38,122 (350)
Prevalence of COVID-19 Risk Factors and Risks of Severe Acute Respiratory Disease are Markedly Higher in Patients with Symptomatic Peripheral Arterial Occlusive Disease. [PDF]
Peters F, Marschall U, Behrendt CA.
europepmc +1 more source
Hyperhomocysteinemia and risk for peripheral arterial occlusive disease in young women [PDF]
Maurice A. A. J. van den Bosch+7 more
openalex +1 more source
The Prevalence and Severity of Pain in Patients With Systemic Sclerosis
ABSTRACT We investigated pain prevalence and severity in systemic sclerosis (SSc) and patient–physician perceptions. This was an internet‐based survey that compared perceptions of pain type, location, severity, associated factors between patients with SSc and physicians, and pain treatment prescription patterns in Japan in March 2023.
Sei‐ichiro Motegi+6 more
wiley +1 more source
In silico analysis of the molecular regulatory networks in peripheral arterial occlusive disease. [PDF]
Guan X, Yang X, Wang C, Bi R.
europepmc +1 more source
Dietary folate and vitamin b6 are independent predictors of peripheral arterial occlusive disease [PDF]
A Wilmink+6 more
openalex +1 more source
Interventional oncology in children: Where are we now?
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel+1 more
wiley +1 more source
Clinical and economic outcomes in thrombolytic treatment of peripheral arterial occlusive disease and deep venous thrombosis [PDF]
Kenneth Ouriel+2 more
openalex +1 more source
Summary The JAK2V617F mutation is associated with increased cardiovascular risk, including ischaemic stroke. This study investigates the prevalence of additional mutations in ischaemic cerebrovascular patients with and without JAK2V617F to better understand the mechanisms contributing to thrombotic risk.
Marie Hvelplund Kristiansen+5 more
wiley +1 more source